title: Quality of life in women with localised breast cancer or malignant melanoma 2 years after initial treatment: a comparison.
abstract: BACKGROUND
  Two thirds of female breast cancer patients and more than 80 % of malignant melanoma patients are diagnosed with localised disease and good prognosis with a 5-year relative survival of more than 90 % in Germany.
  
  
  OBJECTIVE
  This study was conducted to present quality of life (QoL) data from a German population-based cohort of female breast cancer and melanoma patients without recurrence for approximately 2 years after initial diagnosis.
  
  
  METHODS
  In 2003-2004, patients with localised breast cancer and melanoma were recruited from the Munich Cancer Registry (Upper Bavaria, Germany) to answer QoL questionnaires. Differences between breast cancer and melanoma patients were investigated with regard to age and aspects of communication with their medical caregivers.
  
  
  RESULTS
  One thousand three hundred and four breast cancer and 348 melanoma patients were included. Breast cancer patients were about 7 years older and had significantly lower QoL and higher symptom scores than melanoma patients. Communication needs were generally similar in both groups; however, breast cancer patients experienced more empathy from their medical caregivers. In breast cancer patients, communication was an independent factor for all QoL functioning scores.
  
  
  CONCLUSIONS
  Even when faced with a similarly good prognosis, breast cancer patients have a worse QoL than melanoma patients 2 years after diagnosis. An explanation may be more distinctive surgery and systemic therapy, older patients with comorbidities and misunderstood risk communication in breast cancer patients that may stoke anxiety and fears. Further reasons could be unceasing public discussion about breast cancer and its instrumentalisation for political purposes.
authors.affiliation: Munich Cancer Registry (MCR) of the Munich Cancer Centre (MCC) at the Department of Medical Informatics, Biometry and Epidemiology (IBE), Ludwig-Maximilians-University (LMU), Munich, Germany.
authors.forename: Jutta
authors.initials: J
authors.lastname: Engel
authors.forename: Anne
authors.initials: A
authors.lastname: Schlesinger-Raab
authors.forename: Rebecca
authors.initials: R
authors.lastname: Emeny
authors.forename: Dieter
authors.initials: D
authors.lastname: Hölzel
authors.forename: Gabriele
authors.initials: G
authors.lastname: Schubert-Fritschle
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis / Q000523:psychology* / Q000628:therapy; D017028:Caregivers; D016009:Chi-Square Distribution; D015331:Cohort Studies; D003142:Communication; D015897:Comorbidity; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D008545:Melanoma / Q000175:diagnosis / Q000523:psychology* / Q000628:therapy; D008875:Middle Aged; D010817:Physician-Patient Relations; D011788:Quality of Life; D012042:Registries; D011795:Surveys and Questionnaires
references.citation: Ann Oncol. 2010 Dec;21(12):2428-2435
references.pmid: 20494965
references.citation: J Clin Oncol. 1998 Mar;16(3):1188-96
references.pmid: 9508207
references.citation: BMJ. 2000 Apr 1;320(7239):909-13
references.pmid: 10742000
references.citation: J Natl Cancer Inst. 2009 Jun 16;101(12):860-8
references.pmid: 19509357
references.citation: J Surg Oncol. 2009 Jun 1;99(7):447-55
references.pmid: 19418493
references.citation: BMJ. 1999 Nov 6;319(7219):1247-8
references.pmid: 10550091
references.citation: Psychooncology. 2005 Oct;14(10):831-45; discussion 846-7
references.pmid: 16200519
references.citation: J Clin Oncol. 1993 Mar;11(3):570-9
references.pmid: 8445433
references.citation: Ann Oncol. 2009 Aug;20 Suppl 6:vi51-8
references.pmid: 19617298
references.citation: Patient Educ Couns. 2006 Aug;62(2):163-77
references.pmid: 16828665
references.citation: Eur J Cancer. 2001 Jul;37(11):1345-51
references.pmid: 11435063
references.citation: Cancer Surv. 1987;6(3):439-53
references.pmid: 3326657
references.citation: Ann Oncol. 2005 May;16(5):805-16
references.pmid: 15817599
references.citation: JAMA. 2002 Dec 18;288(23):3027-34
references.pmid: 12479768
references.citation: J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
references.pmid: 8433390
references.citation: Ann Oncol. 2003 Mar;14(3):421-7
references.pmid: 12598348
references.citation: Psychooncology. 2010 Feb;19(2):160-9
references.pmid: 19189279
references.citation: Ann Oncol. 2011 Apr;22(4):761-772
references.pmid: 20870912
references.citation: Surgery. 1974 Sep;76(3):376-90
references.pmid: 4136510
references.citation: Eur J Cancer. 2000 May;36(7):834-44
references.pmid: 10785587
references.citation: Psychooncology. 2008 Oct;17(10):1048-52
references.pmid: 18203242
references.citation: J Clin Epidemiol. 1997 Apr;50(4):441-50
references.pmid: 9179103
references.citation: Health Qual Life Outcomes. 2009 Dec 23;7:102
references.pmid: 20030832
references.citation: Value Health. 2008 Mar-Apr;11(2):259-71
references.pmid: 18380638
references.citation: Int J Dermatol. 2013 Jun;52(6):693-704
references.pmid: 23432215